This study evaluated the feasibility of using combined metabolic imaging methodologies, namely 3D lactate-edited proton magnetic resonance spectroscopic imaging and Gallium-68 citrate PET, in patients with glioma using a PET/MR scanner.
This abstract and the presentation materials are available to members only; a login is required.